Insufficient scRNA-seq data for expression of TEX19 at single-cell level.
Insufficient scRNA-seq data for expression of TEX19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 61% | 3.40 | 401 / 653 | 1% | 0.01 | 4 / 605 |
muscle | 46% | 2.59 | 369 / 803 | 0% | 0 | 0 / 0 |
spleen | 46% | 2.22 | 110 / 241 | 0% | 0 | 0 / 0 |
stomach | 31% | 0.98 | 110 / 359 | 4% | 0.15 | 11 / 286 |
liver | 27% | 1.19 | 61 / 226 | 7% | 0.18 | 29 / 406 |
pancreas | 32% | 1.07 | 106 / 328 | 0% | 0 | 0 / 178 |
lung | 25% | 0.98 | 147 / 578 | 5% | 0.50 | 59 / 1155 |
adrenal gland | 29% | 0.95 | 76 / 258 | 0% | 0.01 | 1 / 230 |
intestine | 26% | 0.79 | 251 / 966 | 3% | 0.12 | 15 / 527 |
peripheral blood | 28% | 7.55 | 260 / 929 | 0% | 0 | 0 / 0 |
skin | 26% | 1.11 | 469 / 1809 | 1% | 0.04 | 7 / 472 |
uterus | 19% | 0.86 | 33 / 170 | 4% | 0.10 | 20 / 459 |
brain | 21% | 0.65 | 557 / 2642 | 2% | 0.07 | 17 / 705 |
bladder | 19% | 0.38 | 4 / 21 | 3% | 0.08 | 13 / 504 |
breast | 15% | 0.68 | 68 / 459 | 6% | 0.43 | 72 / 1118 |
esophagus | 19% | 0.61 | 271 / 1445 | 1% | 0.02 | 2 / 183 |
prostate | 20% | 1.18 | 48 / 245 | 0% | 0.01 | 1 / 502 |
kidney | 18% | 0.67 | 16 / 89 | 2% | 0.05 | 16 / 901 |
adipose | 19% | 0.54 | 229 / 1204 | 0% | 0 | 0 / 0 |
ovary | 17% | 0.52 | 30 / 180 | 2% | 0.03 | 8 / 430 |
blood vessel | 11% | 0.29 | 151 / 1335 | 0% | 0 | 0 / 0 |
heart | 11% | 0.29 | 93 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.20 | 2 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010526 | Biological process | retrotransposon silencing |
GO_0007131 | Biological process | reciprocal meiotic recombination |
GO_0008584 | Biological process | male gonad development |
GO_0007283 | Biological process | spermatogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0007140 | Biological process | male meiotic nuclear division |
GO_0001890 | Biological process | placenta development |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0034584 | Molecular function | piRNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TEX19 |
Protein name | Testis-expressed protein 19 |
Synonyms | |
Description | FUNCTION: Required during spermatogenesis and placenta development, participating in the repression of retrotransposable elements and prevent their mobilization. Collaborates with the Piwi-interacting RNA (piRNA) pathway, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins. Interacts with Piwi proteins and directly binds piRNAs, a class of 24 to 30 nucleotide RNAs that are generated by a Dicer-independent mechanism and are primarily derived from transposons and other repeated sequence elements. Also during spermatogenesis, promotes, with UBR2, SPO11-dependent recombination foci to accumulate and drive robust homologous chromosome synapsis (By similarity). Interacts with LINE-1 retrotransposon encoded LIRE1, stimulates LIRE1 polyubiquitination, mediated by UBR2, and degradation, inhibiting LINE-1 retrotransposon mobilization . . |
Accessions | ENST00000333437.5 Q8NA77 |